Methanex is the world’s largest producer and supplier of methanol, a key industrial chemical used in fuels, plastics, and construction materials. Profitability ties closely to global methanol prices and natural gas costs, making its quarterly results a useful gauge for chemical and energy markets. The third quarter played out against ongoing methanol supply disruptions from the Middle East conflict, which have helped support prices even as the company’s average realized price eased slightly from the prior period. Following the 2025 acquisitions of Beaumont and Natgasoline, investors are focused on how effectively the expanded asset base converts favorable pricing into cash flow, debt reduction, and shareholder returns.
For the third quarter of 2026, Methanex posted net income attributable to shareholders of $265 million, or $3.42 per diluted share, compared with $198 million, or $2.45 per share, in the second quarter. The sequential gain largely reflected the absence of an asset impairment charge from the prior quarter, partly offset by a lower average realized price. Adjusted EBITDA came in at $543 million, down from $577 million, while adjusted net income declined to $284 million from $300 million. Revenue reached approximately $1.388 billion, just below the prior quarter’s $1.395 billion yet above consensus estimates near $1.3 billion. Adjusted earnings per share of $3.69 exceeded the roughly $2.86 consensus figure.
Total methanol sales volume increased to 2,595,000 tonnes from 2,555,000 tonnes, driven by higher sales of produced methanol (2,279,000 tonnes versus 2,151,000 tonnes). Production totaled 2,143,000 tonnes, down from 2,213,000 tonnes, as record North American output was offset by lower volumes in Chile and the idling of the Titan plant in Trinidad. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Methanex entered the third-quarter report with solid momentum, supported by elevated methanol prices tied to Middle East supply issues and a larger production footprint. The results delivered a clear beat on both revenue and adjusted earnings versus consensus, underscoring management’s ability to turn favorable industry conditions into stronger financial performance. At the same time, investors are balancing moderating realized prices against guidance for a sequential rebound in the fourth quarter. Attention is also turning to the decision to sell remaining New Zealand natural gas entitlements and indefinitely idle New Zealand production in early 2027, along with the newly approved share-buyback program that signals confidence in the balance sheet and free cash flow.
Management offered an upbeat near-term outlook, expecting higher Adjusted EBITDA in the fourth quarter of 2026. Based on October and November posted prices and current spot pricing, the company projects an average realized price range of approximately $525 to $550 per tonne for those two months. For the full year, Methanex continues to anticipate production of roughly 9.0 million tonnes of methanol (Methanex interest) and 0.3 million tonnes of ammonia, with quarterly variability linked to gas availability, turnarounds, and unplanned outages.
Several factors deserve close attention in the quarters ahead. The path of global methanol prices, especially the duration of Middle East supply disruptions, remains the largest variable for revenue and margins. Natural gas costs and availability will continue to influence production economics, particularly in Chile. The planned idling of New Zealand facilities and sale of remaining natural gas entitlements mark a strategic shift that could trim future volumes but improve long-term cost positioning. Balance sheet and capital allocation decisions are another focus area. Methanex ended the quarter with a cash balance of $912 million and access to a $400 million revolving credit facility, and it provided notice to redeem $300 million of its existing $700 million bonds due in October 2027. With the 5% normal course issuer bid now authorized, the pace of buybacks alongside ongoing debt reduction and the regular quarterly dividend will be worth monitoring.
One tool I rely on for deeper analysis is Tickeron’s AI Screener. It helps me quickly filter stocks using technical patterns, fundamentals, trends, volatility, and AI-driven signals, making it easier to compare MEOH with peers and spot shifting momentum across the chemicals sector without spending hours on manual screening.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
MEOH saw its Momentum Indicator move below the 0 level on November 13, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 97 similar instances where the indicator turned negative. In 66 of the 97 cases, the stock moved further down in the following days. The odds of a decline are at 68%.
The 10-day RSI Indicator for MEOH moved out of overbought territory on November 02, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In 22 of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at 63%.
The Moving Average Convergence Divergence Histogram (MACD) for MEOH turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 32 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 67%.
MEOH moved below its 50-day moving average on November 19, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MEOH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +2.13% 3-day Advance, the price is estimated to grow further. Considering data from situations where MEOH advanced for three days, in 230 of 320 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
MEOH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 199 of 237 cases where MEOH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 84%.
The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. MEOH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 53 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock slightly better than average.
The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MEOH's P/B Ratio (2.000) is slightly higher than the industry average of (1.147). MEOH's P/E Ratio (75.375) is considerably higher than the industry average of (3.243). Projected Growth (PEG Ratio) (0.080) is also within normal values, averaging (3.769). Dividend Yield (0.011) settles around the average of (0.195) among similar stocks. P/S Ratio (1.117) is also within normal values, averaging (0.578).
The Tickeron SMR rating for this company is 86 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a producer of methanol
Industry ChemicalsMajorDiversified